Area of research
Oncology · Complementary and alternative medicine
Research interest
Research focused on Vasculogenic mimicry and Coronavirus disease 2019 (COVID-19), with related work in Neutrophil to lymphocyte ratio, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), China. Notable publications include 'Advanced research on vasculogenic mimicry in cancer', 'The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions', and 'Predictive Value of the Neutrophil-to-Lymphocyte Ratio(NLR) for Diagnosis and Worse Clinical Course of the COVID-19: Findings from Ten Provinces in China'.
MDSCs might be “Achilles heel” for eradicating CSCs
Immunotherapy with radiotherapy fails to improve prognosis of patients with stage IV non-small cell lung cancer: a retrospective cohort analysis of the THUNDER-2 study
Predictive Value of the Neutrophil-to-Lymphocyte Ratio(NLR) for Diagnosis and Worse Clinical Course of the COVID-19: Findings from Ten Provinces in China
Prediction of a competing endogenous RNA co‐expression network as a prognostic marker in glioblastoma
Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study
Association between Early Treatment and Favorable Clinical Outcomes of COVID-19: Evidence from Nine Provinces in China
The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions
Advanced research on vasculogenic mimicry in cancer